Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CCI-779 demonstrates activity in renal cell carcinoma

March 24, 2004

Ecteinascidin-743 induces disease control in soft tissue sarcoma patients

March 24, 2004

Tellurium compound, AS-101, is a potential treatment for alopecia

March 24, 2004

U. of Missouri-Columbia Research Reactor Center to supply holmium-166 to NeoRx

March 24, 2004

Astex presents two series of CDK2 inhibitors for cancer, fungal infections, etc.

March 24, 2004

Antisoma updates progress of two anticancer drug candidates

March 23, 2004

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Chiron discontinues development of tezacitabine

March 23, 2004

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...